Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival

Chen James X.; Rose Steven; White Sarah B.; El-Haddad Ghassan; Fidelman Nicholas; Yarmohammadi Hooman; Sze Daniel; Salem Riad; Metz David; Soulen Michael C.

首页> 外文期刊>Pancreas >Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival

【24h】

Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival

机译：神经内分泌肿瘤肝转移栓塞治疗：肝无进展生存期和总体生存期的预后因素。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pancreas》 |2016年第3期|共1页
作者
Chen James X.; Rose Steven; White Sarah B.; El-Haddad Ghassan; Fidelman Nicholas; Yarmohammadi Hooman; Sze Daniel; Salem Riad; Metz David; Soulen Michael C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival [J] . Chen James X., Rose Steven, White Sarah B., Cardiovascular and Interventional Radiology: A Journal of Imaging in Diagnosis and Treatment . 2017,第1期

机译：神经内分泌肿瘤肝转移的栓塞治疗：肝进展生存和整体生存的预后因素
2. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival [J] . Chen James X., Rose Steven, White Sarah B., Pancreas . 2016,第3期

机译：神经内分泌肿瘤肝转移栓塞治疗：肝无进展生存期和总体生存期的预后因素。
3. Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases [J] . Manguso Nicholas, Nissen Nicholas, Hendifar Andrew, Journal of Surgical Oncology . 2019,第6期

机译：利用肝转放酶影响小肠神经内分泌肿瘤生存的预后因素
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Analysis of prognostic factors for the development of metastases and survival in renal cell carcinoma patients [D] . Cheng, Jed-Sian 2008

机译：肾细胞癌患者转移和存活的预后因素分析
6. Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery [O] . Lea Hitpass, Daniel Heise, Maximilian Schulze-Hagen, 2020

机译：原发性肿瘤的位置是大肠肝转移门静脉栓塞作为主要肝癌手术准备的大肠肝转移患者肝内无进展生存的预后因素。
7. Abstract No. 539 Total burden of liver tumor: poor prognostic factor for survival and treatment response following Y90 radioembolization of hepatic metastases and cholangiocarcinoma [O] . S. Haider, D. Xu, M. Chervonski, 2018

机译：摘要539肝肿瘤的总负担：肝转移和胆管癌的Y90放射性栓塞后的存活和治疗反应差的预后因素
8. Continuous and split-course radiotherapy in locally advanced carcinoma of the uterine cervix. Analyses of local control, distant metastases, crude survival, early and late morbidity and prognostic factors [R] . Pedersen, D. E. 1994

机译：子宫颈局部晚期癌的连续和分裂放疗。分析局部控制，远处转移，原始生存，早期和晚期发病率和预后因素

Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-free Survival and Overall Survival

著录项

相似文献

相关主题

期刊订阅